Evaluating only Doktor.se’s profile at its peak — without knowing the outcome — the model ranked Unit economics as the #1 likely cause. Documented cause: Regulation.
Key Events Timeline
FOUNDING
Doktor.se founded in Stockholm to combine digital consultations with prescription delivery services.
FUNDING
Secured SEK 200M+ from Bonnier and institutional investors to expand nationwide digital pharmacy operations.
ACQUISITION ATTEMPT
Merger talks with KRY collapsed over valuation disagreements as both companies faced post-pandemic revenue decline.
SHUTDOWN
Ceased pharmacy delivery operations in 2023 after TLV pricing constraints made last-mile delivery permanently unviable.
Full Analysis
Free · no account needed
Documented cause
Doktor.se, a Swedish digital pharmacy and telehealth platform backed by Bonnier and others with approximately SEK 500M raised, combined video consultations with prescription delivery services. The company struggled with Sweden's reimbursement model under Tandvårds- och läkemedelsförmånsverket (TLV), which capped drug prices too tightly for profitable delivery. After years of losses and failed merger talks with KRY, Doktor.se ceased consumer pharmacy delivery operations in 2023.
Lesson
“National drug pricing schemes in universal healthcare markets structurally exclude private delivery profitability.”